Publications en collaboration avec des chercheurs de Hadassah Medical Center (7)

2023

  1. Report of consensus panel 2 from the 11th international workshop on Waldenström's macroglobulinemia on the management of relapsed or refractory WM patients

    Seminars in Hematology

2015

  1. Carfilzomib, lenalidomide, and dexamethasone for relapsed multiple myeloma

    New England Journal of Medicine, Vol. 372, Núm. 2, pp. 142-152

2009

  1. Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: Impact of a dose-modification guideline

    British Journal of Haematology, Vol. 144, Núm. 6, pp. 895-903

2008

  1. Efficacy and safety of bortezomib in patients with renal impairment: Results from the APEX phase 3 study

    Leukemia, Vol. 22, Núm. 4, pp. 842-849

2007

  1. Extended follow-up of a phase 3 trial in relapsed multiple myeloma: Final time-to-event results of the APEX trial

    Blood, Vol. 110, Núm. 10, pp. 3557-3560

  2. Safety and efficacy of bortezomib in high-risk and elderly patients with relapsed multiple myeloma

    British Journal of Haematology, Vol. 137, Núm. 5, pp. 429-435

2005

  1. Bortezomib or high-dose dexamethasone for relapsed multiple myeloma

    New England Journal of Medicine, Vol. 352, Núm. 24, pp. 2487-2498